Advances in Research on COVID-19 Vaccination for People Living with HIV  

作　　者：Junyan Jin Xiuwen Wang Raphael Carapito Christiane Moog Bin Su 

机构地区：[1]Beijing Key Laboratory for HIV/AIDS Research,Sino-French Joint Laboratory for Research on Humoral Immune Response to HIV Infection,Clinical and Research Center for Infectious Diseases,Beijing Youan Hospital,Capital Medical University,Beijing 100069,China [2]Laboratoire d’ImmunoRhumatologie Moléculaire,Institut National de la Santéet de la Recherche Médicale(INSERM)UMR_S 1109,Institut Thématique Interdisciplinaire(ITI)de Médecine de Précision de Strasbourg,Transplantex NG,Facultéde Médecine,Fédération Hospitalo-Universitaire OMICARE,Fédération de Médecine Translationnelle de Strasbourg(FMTS),Universitéde Strasbourg,Strasbourg 67000,France

出　　处：《Infectious Diseases & Immunity》2022年第4期213-218,共6页感染性疾病与免疫（英文）

基　　金：supported by the High-Level Public Health Specialized Talents Project of Beijing Municipal Health Commission(2022-2-018);the Ministry of Science and Technology of China(CPL-1233);the National Natural Science Foundation of China(NSFC,81974303);the“Climbing the peak(Dengfeng)”Talent Training Program of Beijing Hospitals Authority(DFL20191701);the Beijing Health Technologies Promotion Program(BHTPP2020);the Beijing Key Laboratory for HIV/AIDS Research(BZ0089).

摘　　要：Introduction In December 2019,multiple cases of aggravated pneumonia of unidentified origin were reported inWuhan,China.These were confirmed to be caused by a novel coronavirus.The World Health Organization(WHO)named the disease coronavirus disease 2019(COVID-19).The International Committee on Taxonomy of Viruses officially identified the novel virus severe acute respiratory syndrome coronavirus 2(SARSCoV-2).[1]Although China is now a low endemic areawith a downward trend in the number of confirmed and suspected cases,[2]the threat of the COVID-19 pandemic remains critical.By mid-March 2022,the cumulative number of reported confirmed cases of COVID-19 worldwide exceeded 450 million,with more than 6 million deaths.[3]Since there is no specific therapeutic drug for the treatment of COVID-19,it is important to control the epidemic by actively promoting SARS-CoV-2 vaccination globally,reducing the risk of viral transmission and the incidence of severe COVID-19,thus improving prognoses.[4]

关 键 词：HIV SARS-CoV-2 COVID-19 VACCINATION PLWH 

分 类 号：R512.91[医药卫生—内科学] R186[医药卫生—临床医学]